TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6619296

Group type: EXPERIMENTAL
Intervention: In-home training of parents and child
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Office based training of parents and child
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Office based training of parents only
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 23
Study: 31003148

Group type: EXPERIMENTAL
Intervention: Guluronic acid (G2013)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Guluronic acid and Naproxen
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Guluronic acid
Number of subjects: 75
Study: 28976985

Group type: EXPERIMENTAL
Intervention: Time spent in company of friends
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 138
Study: 26245756

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSpARC response criteria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACR response criteria
Number of subjects: 0

Group type: COMPARATOR
Intervention: ASDAS and BASDAI response criteria
Number of subjects: 0
Study: 25032771

Group type: EXPERIMENTAL
Intervention: Resorbable collagen barriers supported by an osteosynthesis plate
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nonresorbable titanium‐reinforced expanded polytetrafluoroethylene barriers (control)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 22
Study: 18511533

Group type: EXPERIMENTAL
Intervention: Comprehensive pragmatic manual therapy programme including specific corticosteroid injections (n = 89)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standardized optimized activating care (n = 71)
Number of subjects: 160
Study: 15519086

Group type: EXPERIMENTAL
Intervention: Microsuction ring (19.0 mm diameter)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard suction ring (20.3 mm diameter)
Number of subjects: 33
Study: 10674267

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole/day for 8 weeks
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: 15 or 30 mg lansoprazole long-term treatment
Number of subjects: 295

Group type: COMPARATOR
Intervention: 20 mg omeprazole long-term treatment
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Post-treatment follow-up after 3 months
Number of subjects: 295
Study: 9484683

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue glue
Number of subjects: 86

Group type: COMPARATOR
Intervention: Suturing with interrupted 4/0 plain catgut
Number of subjects: 86
Study: 8318561

Group type: EXPERIMENTAL
Intervention: ABO-identical platelets
Number of subjects: 0

Group type: COMPARATOR
Intervention: ABO-unmatched platelets
Number of subjects: 0

Group type: COMPARATOR
Intervention: ABO-incompatible plasma transfusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABO-identical transfusions
Number of subjects: 0
Study: 3525694

Group type: EXPERIMENTAL
Intervention: 2'-Fluoro-5-iodoarabinosylcytosine (FIAC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Adenine arabinoside (ara-A)
Number of subjects: 34
Study: 31281061

Group type: EXPERIMENTAL
Intervention: Triple therapy (fluticasone furoate-umeclidinium-vilanterol)
Number of subjects: 10355

Group type: EXPERIMENTAL
Intervention: Dual therapy (fluticasone furoate-vilanterol)
Number of subjects: 10355
Study: 28757912

Group type: EXPERIMENTAL
Intervention: Protective lung ventilation (6 mL/kg tidal volume and 10 cm H2O PEEP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (12 mL/kg tidal volume and 0 cm H2O PEEP)
Number of subjects: 60
Study: 27180618

Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group conversation
Number of subjects: 0
Study: 24162448

Group type: EXPERIMENTAL
Intervention: Active lifestyle intervention group (moderate calorie and protein restriction, physical activity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline recommendations only (control group)
Number of subjects: 0
Study: 22986783

Group type: EXPERIMENTAL
Intervention: Handwashing promotion
Number of subjects: 461

Group type: COMPARATOR
Intervention: Control
Number of subjects: 461
Study: 20027349

Group type: EXPERIMENTAL
Intervention: Anaferon (pediatric formulation)
Number of subjects: 0
Study: 18575354

Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral Therapy (CBT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mutual Support Group Therapy (MST)
Number of subjects: 40
Study: 14763633

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11728619

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9207389

Group type: EXPERIMENTAL
Intervention: 20 mg/kg oxamniquine
Number of subjects: 138

Group type: COMPARATOR
Intervention: 40 mg/kg praziquantel
Number of subjects: 138
Study: 10146873

Group type: EXPERIMENTAL
Intervention: Inhaled formoterol
Number of subjects: 145

Group type: COMPARATOR
Intervention: Inhaled salbutamol
Number of subjects: 145
Study: 3301989

Group type: EXPERIMENTAL
Intervention: Interdisciplinary geriatric consultation team
Number of subjects: 404

Group type: COMPARATOR
Intervention: Conventional patterns of care (control)
Number of subjects: 404
Study: 29457221

Group type: EXPERIMENTAL
Intervention: A alleles of SNP rs324015
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: A alleles of SNP rs1059513
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: A alleles of both SNPs
Number of subjects: 262
Study: 27669095

Group type: EXPERIMENTAL
Intervention: Motivational interviewing plus weekly exercise contracting (MI + EC)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Motivational interviewing and weekly contingency management for exercise (MI + CM)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both interventions (MI + EC and MI + CM)
Number of subjects: 70
Study: 24450612

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) training for providers including a 1-day workshop and four 30-minute feedback and coaching sessions.
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) training for providers.
Number of subjects: 878

Group type: COMPARATOR
Intervention: Control group with no additional training enhancements, only mandate compliance.
Number of subjects: 878
Study: 22624993

Group type: EXPERIMENTAL
Intervention: Antioxidant cream
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cream base
Number of subjects: 25

Group type: COMPARATOR
Intervention: Barrier cream
Number of subjects: 25
Study: 20530013

Group type: EXPERIMENTAL
Intervention: Amisulpride (400 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pramipexole dihydrochloride (0.5 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 18029233

Group type: EXPERIMENTAL
Intervention: Physical training (information and verbal instruction to exercise by a physiotherapist or physician)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 314
Study: 16841679

Group type: EXPERIMENTAL
Intervention: Neiyi pill (NP)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Neiyi pill (NP) and Neiyi enema (NE)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Danazol
Number of subjects: 58
Study: 14520726

Group type: EXPERIMENTAL
Intervention: Dornase alfa (Pulmozyme) treatment
Number of subjects: 13684

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 13684
Study: 10983905

Group type: EXPERIMENTAL
Intervention: Exercise and diet (E&D)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Exercise alone (E)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 8993958

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1350513

Group type: EXPERIMENTAL
Intervention: Milacemide (1,200 mg/day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3855724

Group type: EXPERIMENTAL
Intervention: Methyldopa (3.5 mg/kg) with sodium sulfate (13.25 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Methyldopa (3.5 mg/kg) alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Methyldopa with sodium sulfate
Number of subjects: 24
Study: 31161447

Group type: EXPERIMENTAL
Intervention: Robotic-assisted gastric bypass
Number of subjects: 343

Group type: COMPARATOR
Intervention: Laparoscopic gastric bypass
Number of subjects: 343
Study: 29737100

Group type: EXPERIMENTAL
Intervention: 300 mg tenofovir disoproxil fumarate tablets under fasting conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 300 mg tenofovir disoproxil fumarate tablets under high-fat diet conditions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Two preparations of tenofovir tablets
Number of subjects: 24
Study: 27919481

Group type: EXPERIMENTAL
Intervention: SR-Fampridine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25226943

Group type: EXPERIMENTAL
Intervention: Rowing exercises performed for twenty‐five times a set, four sets a day, 3 days a week, for 8 weeks using dependent load deviation type rowing machines.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rowing exercises using previously used water load method.
Number of subjects: 24
Study: 22341736

Group type: COMPARATOR
Intervention: PROMUS Element
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: SYNERGY
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: SYNERGY half dose
Number of subjects: 291
Study: 20337074

Group type: EXPERIMENTAL
Intervention: Porcelain‐fused‐to nickel‐chromium (Ni‐Cr) crown
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Porcelain‐fused‐to nickel‐chromium‐titanium (Ni‐Cr‐Ti) crown
Number of subjects: 50
Study: 17347035

Group type: EXPERIMENTAL
Intervention: Caregiver Reaction Assessment (CRA) questionnaire
Number of subjects: 357
Study: 16338260

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily for 8 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 14
Study: 12223254

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 182

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 182
Study: 9805725

Group type: EXPERIMENTAL
Intervention: Standardised questionnaire administered to pregnant women
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Focus group discussions and in-depth interviews with women
Number of subjects: 1600
Study: 7662241

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (1 g/kg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isocaloric substitute (sucrose, 1.75 g/kg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 12
Study: 2756307

Group type: EXPERIMENTAL
Intervention: Iodine solution (2%)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Barium suspension (1.5%)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Paraffin emulsion (25%)
Number of subjects: 90
Study: 767367

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 21

Group type: COMPARATOR
Intervention: Periodontal dressing
Number of subjects: 21
Study: 31812424

Group type: EXPERIMENTAL
Intervention: Soil warming executed by infrared heater from 2011 to 2015
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soil warming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous soil warming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbe-mediated attenuation of Rs
Number of subjects: 0
Study: 31586218

Group type: EXPERIMENTAL
Intervention: Freestyle perforator flap reduction mammoplasty using handheld Doppler and colored duplex scan for perforator detection.
Number of subjects: 105
Study: 28175941

Group type: EXPERIMENTAL
Intervention: SmartCare/PS
Number of subjects: 126

Group type: COMPARATOR
Intervention: Protocol-driven weaning (Control)
Number of subjects: 126
Study: 25758270

Group type: EXPERIMENTAL
Intervention: Arsenic trioxide-eluting stent (AES)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 212
Study: 22565655

Group type: EXPERIMENTAL
Intervention: Exercise programme aimed at improving handgrip (HS) and pinch strengths (PS) as well as motor coordination of the hand, 20 sessions, twice a week, at-home exercises
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment for hands (control)
Number of subjects: 20
Study: 21733426

Group type: EXPERIMENTAL
Intervention: Walking with no load
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Stair ascent with no load
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Stair descent with no load
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Walking with a front load (13.6 kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Stair ascent with a front load (13.6 kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Stair descent with a front load (13.6 kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Walking with a backpack load (13.6 kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Stair ascent with a backpack load (13.6 kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Stair descent with a backpack load (13.6 kg)
Number of subjects: 17
Study: 19200163

Group type: EXPERIMENTAL
Intervention: Iron-induced platelet aggregation (FIPA) measurement using stainless steel as an agonist
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Iron-induced platelet aggregation (FIPA) measurement
Number of subjects: 111
Study: 17060309

Group type: EXPERIMENTAL
Intervention: Educational intervention aimed at expanding cultural awareness, sensitivity, and competence.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 0
Study: 15589004

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Trandolapril 4 mg/day
Number of subjects: 30
Study: 10866916

Group type: EXPERIMENTAL
Intervention: Wakolime(TM) (1% sevoflurane, 2 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Drägersorb(TM) (1% sevoflurane, 2 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Medisorb(TM) (1% sevoflurane, 2 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Amsorb(TM) (1% sevoflurane, 2 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Wakolime(TM) (2% sevoflurane, 1 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Drägersorb(TM) (2% sevoflurane, 1 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Medisorb(TM) (2% sevoflurane, 1 L/min fresh gas flow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Amsorb(TM) (2% sevoflurane, 1 L/min fresh gas flow)
Number of subjects: 4
Study: 9399748

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose histamine-2 receptor antagonist (H2RA) strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose histamine-2 receptor antagonist (H2RA) strategy
Number of subjects: 0
Study: 1287616

Group type: EXPERIMENTAL
Intervention: Cefaclor AF 375 mg twice daily
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Cefaclor AF 500 mg twice daily
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Cefaclor AF 750 mg twice daily
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Cefaclor 250 mg three times daily
Number of subjects: 1024
Study: 2992839

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (2 mg and 4 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Minocromil (4 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 3373022

Group type: EXPERIMENTAL
Intervention: gp70-2
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: dp72
Number of subjects: 40
Study: 30833367

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) plus lifestyle counseling
Number of subjects: 139
Study: 29231587

Group type: EXPERIMENTAL
Intervention: Jingou diaoyu needling technique combined with Bobath therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bobath therapy
Number of subjects: 60
Study: 25208859

Group type: EXPERIMENTAL
Intervention: 16 Gray SRT
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 24 Gray SRT
Number of subjects: 230

Group type: COMPARATOR
Intervention: Sham SRT
Number of subjects: 230
Study: 23263355

Group type: EXPERIMENTAL
Intervention: idebenone (Catena; 900 mg/d)
Number of subjects: 39

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 39
Study: 21664864

Group type: EXPERIMENTAL
Intervention: Externally-paced training at preferred movement frequency
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Externally-paced training at more demanding frequency
Number of subjects: 12

Group type: COMPARATOR
Intervention: Self-paced training
Number of subjects: 12
Study: 19463354

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZoMaxx)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (Taxus)
Number of subjects: 401
Study: 17070426

Group type: EXPERIMENTAL
Intervention: Baseline echocardiography (echo group)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor antagonist therapy in echo group
Number of subjects: 177

Group type: COMPARATOR
Intervention: Angiotensin II receptor antagonist therapy in control group
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Mean left ventricular mass index after 6 months
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Mean diastolic 24-h ambulatory BP monitoring after 6 months
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Mean systolic and diastolic office BP after 6 months
Number of subjects: 177
Study: 12668364

Group type: EXPERIMENTAL
Intervention: Ziprasidone (40-80 mg twice daily)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 10743446

Group type: EXPERIMENTAL
Intervention: Ketamine (bolus 0.1 mg kg‐1 over 10 min followed by infusion of 7 micrograms kg‐1 min‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lidocaine (5 mg kg‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study: 8941101

Group type: EXPERIMENTAL
Intervention: Mental stress tasks (simulated public speaking and the Stroop Color-Word Test)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Mental stress tasks
Number of subjects: 29
Study: 1383302

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Attention and information
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 30
Study: 3888337

Group type: COMPARATOR
Intervention: Simple closure (Group I, 33 patients)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Definitive surgery (Group II, 32 patients)
Number of subjects: 78
Study: 30176216

Group type: EXPERIMENTAL
Intervention: Intermittent heat acclimation (INT) - 8 sessions over 15 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Continuous heat acclimation (CON) - 8 sessions over 8 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both INT and CON
Number of subjects: 16
Study: 29319935

Group type: EXPERIMENTAL
Intervention: Tablet A (50 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tablet B (50 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oral solution (50 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All formulations (Tablet A, Tablet B, Oral Solution)
Number of subjects: 16
Study: 27875528

Group type: EXPERIMENTAL
Intervention: Seasonal Malaria Chemoprevention (SMC) with sulfadoxine‐pyrimethamine (SP) plus amodiaquine (AQ)
Number of subjects: 780000

Group type: COMPARATOR
Intervention: Control (no SMC)
Number of subjects: 780000
Study: 24894963

Group type: EXPERIMENTAL
Intervention: Bupropion 150 mg twice daily
Number of subjects: 84
Study: 22403324

Group type: EXPERIMENTAL
Intervention: Pyronaridine/Artesunate (PA) for 3 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Pyronaridine/Artesunate (PA) with Ritonavir (100 mg twice daily for 17 days, PA administered on Days 8-10)
Number of subjects: 34
Study: 20353110

Group type: COMPARATOR
Intervention: Group A: Routine treatments in western medicine including gastrointestinal decompression, parenteral nutrition, anti-infection, supportive therapy.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Group B: Electroacupuncture in Zusanli (ST 36), Shangjuxu (ST 37) in addition to Group A treatments.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Group C: Acupoint injection with Neostigmine in Dachangshu (BL 25), Zusanli (ST 36) in addition to Group A treatments.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Group D: All treatments from Groups A, B, and C.
Number of subjects: 240
Study: 18279216

Group type: EXPERIMENTAL
Intervention: MDI-S (metered-dose inhaler with spacer)
Number of subjects: 21

Group type: COMPARATOR
Intervention: DPI (dry powder inhaler)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MDI-S
Number of subjects: 21

Group type: COMPARATOR
Intervention: DPI
Number of subjects: 21
Study: 16169341

Group type: EXPERIMENTAL
Intervention: Levosimendan (10 minutes bolus with 12 microg/kg followed by 0.1 microg/kg per minute for 24 hours)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 12110497

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFNalpha) plus interleukin-2 (IL-2) with or without cisplatin
Number of subjects: 131

Group type: COMPARATOR
Intervention: Interferon-alpha (IFNalpha) plus interleukin-2 (IL-2) with cisplatin
Number of subjects: 131
Study: 10220012

Group type: EXPERIMENTAL
Intervention: ‐141C Del allele in schizophrenia patients (n = 50)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control subjects (n = 51)
Number of subjects: 101
Study: 8556848

Group type: EXPERIMENTAL
Intervention: Attention to color or shape (selective attention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different dimensions judged for two stimuli (color and shape)
Number of subjects: 0
Study: 2228819

Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 47
Study: 156408

Group type: EXPERIMENTAL
Intervention: Midline incision
Number of subjects: 49

Group type: COMPARATOR
Intervention: Subcostal incision
Number of subjects: 49